Clinical Trials Sponsored by National institute of Siddha

Total 26653 results

National Cancer Institute (NCI)

Completed

Questionnaire Pre-Test Study

Cancer

United States
National Cancer Institute (NCI)

Completed

Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health

Bladder Cancer

United States
National Cancer Institute (NCI)

Completed

Biomarkers for Breast Cancer Risk in African American Women

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Analyses of Human Samples Collected in Clinical Trials

Leukemia, Myeloid | Neoplasm Metastasis | Prostate Cancer | Leukemia, Lymphoid

United States, Netherlands
National Cancer Institute (NCI)

Completed

Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease

Sclerotic Graft Versus Host Disease | Imatinib Mesylate

United States
National Cancer Institute (NCI)

Withdrawn

Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatocellular Cancer

United States
National Cancer Institute (NCI)

Terminated

Costa Rican Natural History Study of HPV and Cervical Neoplasia

Cervical Neoplasia

Costa Rica
National Cancer Institute (NCI)

Completed

Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident

Thyroid Cancer | Non-Cancer Thyroid Disease | Non Thyroid Cancer

Belarus
National Cancer Institute (NCI)

Terminated

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Graft vs Host Disease | Graft-Versus-Host Disease | Chronic Graft vs. Host Disease

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)

Ovarian Neoplasm

United States
National Cancer Institute (NCI)

Completed

Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study

Pediatric Leukemia | Other Pediatric Cancers

United States
National Cancer Institute (NCI)

Completed

Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer

Stomach Cancer | Gastric Cancer

United States
National Cancer Institute (NCI)

Completed

Maternal and Umbilical Cord Hormone Concentrations in Twin and Singleton Pregnancies

Normal Pregnancy

United States
National Cancer Institute (NCI)

Completed

Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

Common Variable Immunodeficiency | Primary T-cell Immunodeficiency Disorders

United States
National Cancer Institute (NCI)

Terminated

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Hemophilia | AIDS

United States
National Cancer Institute (NCI)

Completed

Message Testing for Tobacco-Related Corrective Statements

Smoking | Communication | Tobacco

United States
National Cancer Institute (NCI)

Completed

Genetic Analysis of Patients With Pseudoxanthoma Elasticum

Pseudoxanthoma Elasticum | PXE

United States
National Cancer Institute (NCI)

Completed

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

Sarcoma | Lymphoma | Neuroblastoma | Wilm's Tumor

United States
National Cancer Institute (NCI)

Completed

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

Head and Neck Cancer | Laryngeal Cancer | Oral Cancer | Carcinoma, Squamous | Pharyngeal Cancer

United States
National Eye Institute (NEI)

Terminated

Family Studies of Uveal Coloboma

Coloboma

United States
National Cancer Institute (NCI)

Terminated

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Leukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins Lymphoma

United States
National Cancer Institute (NCI)

Completed

AZD7451 for Recurrent Gliomas

Glioblastoma Multiforme

United States
National Cancer Institute (NCI)

Completed

Chordoma Family Study

Chordoma

United States
National Cancer Institute (NCI)

Completed

Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

Cancer | HIV

United States
National Cancer Institute (NCI)

Terminated

Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma

Neoplasms | Mycosis Fungoides | Cutaneous T-Cell Lymphoma

United States
National Cancer Institute (NCI)

Completed

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Non-Small Cell Lung Cancer (Stage III) | Colon Cancer (Stage II &Amp; III) | Rectal Cancer (Stage III)

United States
National Cancer Institute (NCI)

Withdrawn

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

Diffuse, Large B-cell Lymphoma | Lymphoma, Diffuse Large-Cell | Lymphoma, Diffuse Large-Cell B-cell | Large-Cell Lymphoma, Diffuse
National Cancer Institute (NCI)

Completed

Community Cancer Centers Pilot Patient Survey

Cancer | Malignant Neoplasms

United States
National Cancer Institute (NCI)

Completed

Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients

Fungus Disease

United States
National Cancer Institute (NCI)

Completed

BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Cell Lines From High-Risk Breast Tissue

Healthy

United States
National Cancer Institute (NCI)

Withdrawn

Imaging Studies and the Development of Multiple Myeloma

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma
National Cancer Institute (NCI)

Completed

Radiation Exposure and Thyroid Disease in Kazakhstan

Thyroid Cancer | Thyroid Nodules | Other Thyroid Disease

Kazakhstan
National Cancer Institute (NCI)

Completed

Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing

Thyroid Cancer

Kazakhstan
National Cancer Institute (NCI)

Completed

Methods in Education for Breast Cancer Genetics

Breast Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma

HIV Infections | HIV Seropositivity | Kaposi's Sarcoma

United States
National Eye Institute (NEI)

Completed

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases

Corneal Dystrophies, Hereditary | Corneal Disease

United States, China, Italy
National Cancer Institute (NCI)

Completed

A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province

Precancerous Gastric Lesions

China
National Cancer Institute (NCI)

Completed

PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

Squamous Cell Carcinoma

United States
National Cancer Institute (NCI)

Withdrawn

A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas

Astrocytoma | Glioblastoma Multiforme | Ependymoma | PNET | Brainstem Glioma
National Cancer Institute (NCI)

Completed

Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

Lung | Brain | Breast | Prostate | Endometrial

United States
National Cancer Institute (NCI)

Completed

An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer

Metastatic Melanoma | Renal Cell Cancer

United States
National Cancer Institute (NCI)

Completed

Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation

Radiation Exposure

United States
National Cancer Institute (NCI)

Completed

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Hepatocellular Carcinoma | Biliary Tract Neoplasms | Liver Cancer | Biliary Cancer | Heptocellular Cancer

United States
National Cancer Institute (NCI)

Terminated

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer

Metastatic Cancer | Metastatic Melanoma | Renal Cancer

United States
National Cancer Institute (NCI)

Completed

Perspective-taking, and Examining the Clinical Trial Informed Consent Process

Emotions | Informed Consent

United States
National Cancer Institute (NCI)

Completed

Evaluation of National Cancer Institute Young Adult Stop-Smoking Program

Smoking | Smoking Cessation | Cigarette Smoking | Tobacco, Smoking

United States
National Eye Institute (NEI)

Completed

People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial

Retinoschisis | X-Linked

United States
National Cancer Institute (NCI)

Terminated

Enzastaurin to Treat Recurrent Brain Tumor

Glioma

United States

Clinical Trials Sponsored by National institute of Siddha

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations